Menu

Clinical trials

‘Return to life, return to work’ clinical research grants for 2019 

Applications are now closed

The Stroke Foundation is facilitating the research grants for the ‘Return to Life, Return to Work’ clinical trials that are supported by the Australian Government's Medical Research Future Fund (MRFF). Applications are now closed and the announcement of successful applicants will be made in February 2019 via Stroke Foundation’s website, media and social media channels.

Following this, the successful research teams will undertake a process through which people can express their interest to be involved.

The ‘Return to life, return to work' initiative will fund projects aimed at developing innovative recovery and rehabilitation clinical interventions for younger stroke survivors in Australia - an emerging priority area with unmet needs. These projects will continue to accelerate important neurological research and support Australian researchers to be at the forefront of finding solutions for stroke recovery.

  1. Clinical Trial: Perispinal Etanercept (PSE) as a therapy promoting recovery after chronic stroke for younger stroke survivors in Australia (particularly those of working age).
  2. Clinical Trial: Return to work (RTW) for younger stroke survivors in Australia.

For any enquiries, please contact:

Stroke Foundation Compliance Officer, Michelle Adamson
Email: research@strokefoundation.org.au
Telephone: 03 9918 7215

Acknowledgement

Funding for this research has been provided by the Medical Research Future Fund (MRFF). The MRFF has been established by the Australian Government to provide grants of financial assistance to support health and medical research and innovation, with the objective of improving the health and wellbeing of Australians. MRFF funding has been provided to Stroke Foundation under the MRFF Accelerated Research Program announced as part the MRFF’s disbursement package in October 2018. Further information on the MRFF and disbursements are available at www.health.gov.au/mrff.